Loading...
ALK ligand ALKAL2 potentiates MYCN‐driven neuroblastoma in the absence of ALK mutation
High‐risk neuroblastoma (NB) is responsible for a disproportionate number of childhood deaths due to cancer. One indicator of high‐risk NB is amplification of the neural MYC (MYCN) oncogene, which is currently therapeutically intractable. Identification of anaplastic lymphoma kinase (ALK) as an NB o...
Na minha lista:
| Udgivet i: | EMBO J |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
John Wiley and Sons Inc.
2021
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7849294/ https://ncbi.nlm.nih.gov/pubmed/33411331 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.15252/embj.2020105784 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|